Literature DB >> 31698453

Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion.

Tomohiro Umezu1,2, Satoshi Imanishi3, Seiichiro Yoshizawa1, Chiaki Kawana1, Junko H Ohyashiki2, Kazuma Ohyashiki1,2.   

Abstract

Bone marrow stromal cells (BMSCs) interact with multiple myeloma (MM) cells in the bone marrow and create a permissive microenvironment for MM cell proliferation and survival. In this study, we investigated the role of extracellular vesicles (EVs) from BMSCs derived from patients with MM (MM-BMSCs). EV-encapsulated miR-10a expression was high while intracellular miR-10a was low in MM-BMSCs. We therefore hypothesized that miR-10a was packaged into EVs that were actively released into the extracellular space. Inhibition of EV release resulted in accumulation of intracellular miR-10a, inhibition of cell proliferation, and induction of apoptosis in MM-BMSCs. In contrast, proliferation and apoptosis of BMSCs derived from healthy individuals were unaffected by inhibition of EV release. Furthermore, miR-10a derived from MM-BMSCs was transferred into MM cells via EVs and enhanced their proliferation. These results suggest that inhibition of EV release induced apoptosis in MM-BMSCs and inhibited MM cell proliferation, indicating a possible role for MM-BMSC-targeted therapy.
© 2019 by The American Society of Hematology.

Entities:  

Year:  2019        PMID: 31698453      PMCID: PMC6855114          DOI: 10.1182/bloodadvances.2019000403

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  43 in total

1.  Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes.

Authors:  Taketoshi Kajimoto; Taro Okada; Satoshi Miya; Lifang Zhang; Shun-ichi Nakamura
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 2.  Functional transferred DNA within extracellular vesicles.

Authors:  Jin Cai; Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Exp Cell Res       Date:  2016-10-14       Impact factor: 3.905

3.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.

Authors:  Laura Santangelo; Giorgio Giurato; Carla Cicchini; Claudia Montaldo; Carmine Mancone; Roberta Tarallo; Cecilia Battistelli; Tonino Alonzi; Alessandro Weisz; Marco Tripodi
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

Review 4.  Extracellular vesicles: biology and emerging therapeutic opportunities.

Authors:  Samir EL Andaloussi; Imre Mäger; Xandra O Breakefield; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2013-04-15       Impact factor: 84.694

5.  A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

Authors:  Srinivasan Madhusudan; Martin Foster; Sethupathi R Muthuramalingam; Jeremy P Braybrooke; Susan Wilner; Kulwinder Kaur; Cheng Han; Susan Hoare; Frances Balkwill; Denis C Talbot; Trivadi S Ganesan; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

6.  miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death.

Authors:  Adam Bryant; Catalina A Palma; Vivek Jayaswal; Yee Wa Yang; Mark Lutherborrow; David Df Ma
Journal:  Mol Cancer       Date:  2012-02-20       Impact factor: 27.401

Review 7.  Engineering Exosomes for Cancer Therapy.

Authors:  Katie E Gilligan; Róisín M Dwyer
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

8.  Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.

Authors:  Jasenka Guduric-Fuchs; Anna O'Connor; Bailey Camp; Christina L O'Neill; Reinhold J Medina; David A Simpson
Journal:  BMC Genomics       Date:  2012-08-01       Impact factor: 3.969

Review 9.  Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer.

Authors:  Shin Hamada; Atsushi Masamune; Tooru Shimosegawa
Journal:  Front Physiol       Date:  2013-11-11       Impact factor: 4.566

10.  Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a.

Authors:  Qian Cheng; Xin Li; Jingru Liu; Qinmao Ye; Yanfang Chen; Sanqin Tan; Jing Liu
Journal:  Stem Cells Int       Date:  2017-11-27       Impact factor: 5.443

View more
  7 in total

1.  Editorial: Understanding the RNA Species in the Extracellular Vesicles of Multiple Myeloma.

Authors:  Maoshan Chen; Rong Xu; Jing Zhang; Andrew Spencer; Richard Simpson
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 2.  MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.

Authors:  Vanessa Desantis; Ilaria Saltarella; Aurelia Lamanuzzi; Assunta Melaccio; Antonio Giovanni Solimando; Maria Addolorata Mariggiò; Vito Racanelli; Angelo Paradiso; Angelo Vacca; Maria Antonia Frassanito
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 3.  Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.

Authors:  Amro M Soliman; Teoh Seong Lin; Pasuk Mahakkanukrauh; Srijit Das
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

4.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.

Authors:  Iago Carvalho Schultz; Ana Paula Santin Bertoni; Márcia Rosângela Wink
Journal:  Stem Cell Rev Rep       Date:  2021-01-28       Impact factor: 5.739

5.  EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS.

Authors:  Fei Li; Xin Zhao; Rui Sun; Jinxin Ou; Junyu Huang; Nanyan Yang; Ting Xu; Jingyao Li; Xiner He; Chaoyi Li; Mo Yang; Qing Zhang
Journal:  J Extracell Vesicles       Date:  2020-10-30

Review 6.  The "Vesicular Intelligence" Strategy of Blood Cancers.

Authors:  Dorian Forte; Martina Barone; Francesca Palandri; Lucia Catani
Journal:  Genes (Basel)       Date:  2021-03-13       Impact factor: 4.096

7.  FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma.

Authors:  Haipeng Jia; Xiaofen Zhang; Xinxin Liu; Ruifang Qiao; Yan Liu; Sulong Lv; Hongbo Zhu; Jie Wang; Qiuhong Kong; Hong Zhang; Zhirong Zhang
Journal:  Front Med (Lausanne)       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.